Education
About Us
Working with TipRanks
Follow Us
Steven Weber Insider Profile
4 Followers
Steven Weber, VP, Controller&Princ Acctg Off at Spyre Therapeutics, holds ― shares in Spyre Therapeutics (Ticker: SYRE), holds 26.53K shares in IGM Biosciences (Ticker: IGMS), holds ― shares in Pulse Biosciences (Ticker: PLSE). Most recently, Steven Weber ― shares of Spyre Therapeutics on ― for an estimated value of ―.
Steven Weber Spyre Therapeutics (SYRE)VP, Controller&Princ Acctg Off
Spyre Therapeutics (SYRE)
VP, Controller&Princ Acctg Off
Ranked #11,644 out of 106,013 Corporate Insiders
Profitable Transactions
3 out of 3 Profitable Transactions
Average Return
+88.30%
Average return per transaction
Time Frame
Compare to
Insider Holdings
Steven Weber does not currently own shares as a corporate insider.
A breakdown of Steven Weber's holdings
Insider Roles
Roles that Steven Weber holds in companies
Most Profitable Insider Trade
Stock:
IGM Biosciences
(IGMS)
(IGMS)
Rating:Informative Sell
Date:Sep 17, 2024 - Sep 17, 2025
Return:+92.80%
The most profitable trade made by Steven Weber
Steven Weber's Trading History
Spyre Therapeutics
―
VP, Controller&Princ Acctg Off
―
―
IGM Biosciences
Jun 20, 2025
―
Informative Sell
578.34
$33.69K
Pulse Biosciences
―
Principal Accounting Officer
―
―
List of latest transactions for each holding click on a transaction to see Steven Weber's performance on stock
You May Also Like
Steven Weber insider profile FAQ
What is the percentage of profitable transactions made by Steven Weber?
The percentage of profitable transactions made by Steven Weber is 100%.
What is the average return per transaction made by Steven Weber?
The average return per transaction made by Steven Weber is 88.30%.
What stocks does Steven Weber hold?
Steven Weber holds: SYRE, IGMS, PLSE stocks.
What was Steven Weber’s latest transaction?
Steven Weber latest transaction was an Uninformative Buy of ―.
What was Steven Weber's most profitable transaction?
Steven Weber’s most profitable transaction was an Informative Sell of IGMS stock on September 17, 2024. The return on the trade was 92.80%.
What is Steven Weber's role in Spyre Therapeutics?
Steven Weber's role in Spyre Therapeutics is VP, Controller&Princ Acctg Off.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.